US 9637483
Heterocyclic compound
granted A61PA61P1/04A61P17/00
Quick answer
US patent 9637483 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/04, A61P17/00, A61P17/06, A61P19/08